Lataa...

Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence

The relevant role in cancer played by the tyrosine kinase receptor encoded by the MET oncogene led to the development of specific inhibitors, some of which are now in advanced phases of clinical trials. Previous experience has shown that the main limit to the efficacy of most targeted treatments is...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Oncol
Päätekijät: Martin, Valentina, Corso, Simona, Comoglio, Paolo M., Giordano, Silvia
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528600/
https://ncbi.nlm.nih.gov/pubmed/25011627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.06.010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!